Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts.


Journal

The Lancet. Public health
ISSN: 2468-2667
Titre abrégé: Lancet Public Health
Pays: England
ID NLM: 101699003

Informations de publication

Date de publication:
03 2022
Historique:
received: 26 10 2021
revised: 16 12 2021
accepted: 17 12 2021
pubmed: 6 3 2022
medline: 26 4 2022
entrez: 5 3 2022
Statut: ppublish

Résumé

Although 10 000 steps per day is widely promoted to have health benefits, there is little evidence to support this recommendation. We aimed to determine the association between number of steps per day and stepping rate with all-cause mortality. In this meta-analysis, we identified studies investigating the effect of daily step count on all-cause mortality in adults (aged ≥18 years), via a previously published systematic review and expert knowledge of the field. We asked participating study investigators to process their participant-level data following a standardised protocol. The primary outcome was all-cause mortality collected from death certificates and country registries. We analysed the dose-response association of steps per day and stepping rate with all-cause mortality. We did Cox proportional hazards regression analyses using study-specific quartiles of steps per day and calculated hazard ratios (HRs) with inverse-variance weighted random effects models. We identified 15 studies, of which seven were published and eight were unpublished, with study start dates between 1999 and 2018. The total sample included 47 471 adults, among whom there were 3013 deaths (10·1 per 1000 participant-years) over a median follow-up of 7·1 years ([IQR 4·3-9·9]; total sum of follow-up across studies was 297 837 person-years). Quartile median steps per day were 3553 for quartile 1, 5801 for quartile 2, 7842 for quartile 3, and 10 901 for quartile 4. Compared with the lowest quartile, the adjusted HR for all-cause mortality was 0·60 (95% CI 0·51-0·71) for quartile 2, 0·55 (0·49-0·62) for quartile 3, and 0·47 (0·39-0·57) for quartile 4. Restricted cubic splines showed progressively decreasing risk of mortality among adults aged 60 years and older with increasing number of steps per day until 6000-8000 steps per day and among adults younger than 60 years until 8000-10 000 steps per day. Adjusting for number of steps per day, comparing quartile 1 with quartile 4, the association between higher stepping rates and mortality was attenuated but remained significant for a peak of 30 min (HR 0·67 [95% CI 0·56-0·83]) and a peak of 60 min (0·67 [0·50-0·90]), but not significant for time (min per day) spent walking at 40 steps per min or faster (1·12 [0·96-1·32]) and 100 steps per min or faster (0·86 [0·58-1·28]). Taking more steps per day was associated with a progressively lower risk of all-cause mortality, up to a level that varied by age. The findings from this meta-analysis can be used to inform step guidelines for public health promotion of physical activity. US Centers for Disease Control and Prevention.

Sections du résumé

BACKGROUND
Although 10 000 steps per day is widely promoted to have health benefits, there is little evidence to support this recommendation. We aimed to determine the association between number of steps per day and stepping rate with all-cause mortality.
METHODS
In this meta-analysis, we identified studies investigating the effect of daily step count on all-cause mortality in adults (aged ≥18 years), via a previously published systematic review and expert knowledge of the field. We asked participating study investigators to process their participant-level data following a standardised protocol. The primary outcome was all-cause mortality collected from death certificates and country registries. We analysed the dose-response association of steps per day and stepping rate with all-cause mortality. We did Cox proportional hazards regression analyses using study-specific quartiles of steps per day and calculated hazard ratios (HRs) with inverse-variance weighted random effects models.
FINDINGS
We identified 15 studies, of which seven were published and eight were unpublished, with study start dates between 1999 and 2018. The total sample included 47 471 adults, among whom there were 3013 deaths (10·1 per 1000 participant-years) over a median follow-up of 7·1 years ([IQR 4·3-9·9]; total sum of follow-up across studies was 297 837 person-years). Quartile median steps per day were 3553 for quartile 1, 5801 for quartile 2, 7842 for quartile 3, and 10 901 for quartile 4. Compared with the lowest quartile, the adjusted HR for all-cause mortality was 0·60 (95% CI 0·51-0·71) for quartile 2, 0·55 (0·49-0·62) for quartile 3, and 0·47 (0·39-0·57) for quartile 4. Restricted cubic splines showed progressively decreasing risk of mortality among adults aged 60 years and older with increasing number of steps per day until 6000-8000 steps per day and among adults younger than 60 years until 8000-10 000 steps per day. Adjusting for number of steps per day, comparing quartile 1 with quartile 4, the association between higher stepping rates and mortality was attenuated but remained significant for a peak of 30 min (HR 0·67 [95% CI 0·56-0·83]) and a peak of 60 min (0·67 [0·50-0·90]), but not significant for time (min per day) spent walking at 40 steps per min or faster (1·12 [0·96-1·32]) and 100 steps per min or faster (0·86 [0·58-1·28]).
INTERPRETATION
Taking more steps per day was associated with a progressively lower risk of all-cause mortality, up to a level that varied by age. The findings from this meta-analysis can be used to inform step guidelines for public health promotion of physical activity.
FUNDING
US Centers for Disease Control and Prevention.

Identifiants

pubmed: 35247352
pii: S2468-2667(21)00302-9
doi: 10.1016/S2468-2667(21)00302-9
pmc: PMC9289978
mid: NIHMS1787838
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e219-e228

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL136266
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM104940
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 AG999999
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests AEP and CFP received funding for this project from US Centers for Disease Control and Prevention (CDC) Intergovernmental Personnel Act Agreement. BJJ receives grant funding through the British Heart Foundation. MRC and RSV have received grant funding through National Heart Lung and Blood Institute, National Institutes of Health (NIH). I-ML, KPG, and PP receive grant funding through NIH. KRE receives grant funding through NIH, Robert Wood Johnson Foundation, US Department of Transportation, and North Carolina Department of Transportation; receives consulting fees from NIH; and is on the Board of Trustees with the American College of Sports Medicine. DD has received grant funding through German Research Foundation, travel expenses for 10th International Meeting on Ageing, honoraria for being an instructor at Boston University School of Public Health, been an unpaid speaker for German Society of Epidemiology, and been an unpaid member of the Alumni Leadership Council of Boston University School of Public Health. JS receives grant funding through National Institutes on Aging, NIH. All other authors declare no competing interests.

Références

Sports Med. 2022 Jan;52(1):89-99
pubmed: 34417979
PLoS One. 2016 Oct 19;11(10):e0165127
pubmed: 27760234
Med Sci Sports Exerc. 2013 Oct;45(10):1995-2001
pubmed: 23568091
Med Sci Sports Exerc. 2009 Jul;41(7):1510-30
pubmed: 19516148
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
JAMA. 2020 Mar 24;323(12):1151-1160
pubmed: 32207799
JAMA Netw Open. 2021 Sep 1;4(9):e2124516
pubmed: 34477847
Br J Sports Med. 2020 Dec;54(24):1451-1462
pubmed: 33239350
Am J Clin Nutr. 1997 Apr;65(4 Suppl):1220S-1228S; discussion 1229S-1231S
pubmed: 9094926
BMC Public Health. 2018 Apr 23;18(1):540
pubmed: 29685125
Br J Sports Med. 2018 Jun;52(12):776-788
pubmed: 29858465
Am J Prev Med. 2017 Apr;52(4):541-548
pubmed: 28062274
JAMA Intern Med. 2019 Aug 01;179(8):1105-1112
pubmed: 31141585
J Intern Med. 2020 Apr;287(4):373-394
pubmed: 32107805
Int J Behav Nutr Phys Act. 2008 Nov 06;5:56
pubmed: 18990237
Age Ageing. 2015 Mar;44(2):261-8
pubmed: 25377744
Int J Behav Nutr Phys Act. 2020 Nov 10;17(1):137
pubmed: 33168018
Prev Med. 2013 Dec;57(6):855-9
pubmed: 24096141
J Sport Health Sci. 2021 May 23;:
pubmed: 34029758
BMJ. 2019 Aug 21;366:l4570
pubmed: 31434697
PLoS One. 2015 Nov 04;10(11):e0141274
pubmed: 26536618
Int J Behav Nutr Phys Act. 2020 Jun 20;17(1):78
pubmed: 32563261
JAMA Netw Open. 2019 Apr 5;2(4):e192745
pubmed: 31002329
Med Sci Sports Exerc. 2018 Jun;50(6):1315-1322
pubmed: 29381649
BMC Public Health. 2020 Nov 30;20(1):1830
pubmed: 33256704
Stat Methods Med Res. 2019 May;28(5):1579-1596
pubmed: 29742975
Cancer. 2017 Jun 1;123(11):2014-2024
pubmed: 28171707
Scand J Med Sci Sports. 2020 Sep;30(9):1705-1711
pubmed: 32427398
Prev Med. 2019 Apr;121:40-46
pubmed: 30742870
JAMA Cardiol. 2019 Feb 1;4(2):174-181
pubmed: 30698608
PLoS One. 2016 Apr 15;11(4):e0153779
pubmed: 27082963
Br J Sports Med. 2019 Aug;53(16):1013-1020
pubmed: 29440040
Int J Behav Nutr Phys Act. 2020 Mar 14;17(1):39
pubmed: 32169059
JAMA. 1989 Nov 3;262(17):2395-401
pubmed: 2795824
J Sci Med Sport. 2020 Mar;23(3):276-282
pubmed: 31615727
Hum Mov Sci. 2020 Jun;71:102611
pubmed: 32452428
Am J Health Promot. 2012 Jan-Feb;26(3):152-9
pubmed: 22208412
Int J Ther Rehabil. 2012 Jul 3;19(7):387-393
pubmed: 24795762
BMJ Open Diabetes Res Care. 2018 Jul 19;6(1):e000523
pubmed: 30073088
BMJ Evid Based Med. 2018 Jun;23(3):84-86
pubmed: 29650725
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Amanda E Paluch (AE)

Department of Kinesiology and Institute for Applied Life Sciences, University of Massachusetts Amherst, Amherst, MA, USA. Electronic address: apaluch@umass.edu.

Shivangi Bajpai (S)

Department of Kinesiology and Institute for Applied Life Sciences, University of Massachusetts Amherst, Amherst, MA, USA.

David R Bassett (DR)

Department Kinesiology, Recreation, and Sport Studies, University of Tennessee, Knoxville, TN, USA.

Mercedes R Carnethon (MR)

Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Ulf Ekelund (U)

Department of Sport Medicine, Norwegian School of Sport Sciences, Norwegian Institute of Public Health, Oslo, Norway; Department of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway.

Kelly R Evenson (KR)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina Chapel Hill, Chapel Hill, NC, USA.

Deborah A Galuska (DA)

Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Barbara J Jefferis (BJ)

Department of Primary Care and Population Health, UCL Medical School, London, UK.

William E Kraus (WE)

Duke Molecular Physiology Institute and Division of Cardiology, Department of Medicine, Duke University, Durham, NC, USA.

I-Min Lee (IM)

Brigham and Women's Hospital, Harvard Medical School, Boston MA, USA; Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, USA.

Charles E Matthews (CE)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.

John D Omura (JD)

Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Alpa V Patel (AV)

Department of Population Science, American Cancer Society, Atlanta, GA, USA.

Carl F Pieper (CF)

Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC.

Erika Rees-Punia (E)

Department of Population Science, American Cancer Society, Atlanta, GA, USA.

Dhayana Dallmeier (D)

Agaplesion Bethesda Clinic, Research Unit on Ageing, Ulm, Germany; Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

Jochen Klenk (J)

Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany; Department of Clinical Gerontology, Robert Bosch Hospital, Stuttgart, Germany; IB University of Applied Health and Social Sciences, Stuttgart, Germany.

Peter H Whincup (PH)

Population Health Research Institute, St George's, University of London, London, UK.

Erin E Dooley (EE)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Kelley Pettee Gabriel (K)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Priya Palta (P)

Departments of Medicine and Epidemiology, Columbia University Irving Medical Center, New York, NY, USA.

Lisa A Pompeii (LA)

Department of Pediatrics, Center for Epidemiology and Population Health, Baylor College of Medicine, Houston, TX, USA.

Ariel Chernofsky (A)

Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

Martin G Larson (MG)

Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

Ramachandran S Vasan (RS)

Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA; Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

Nicole Spartano (N)

Department of Endocrinology, Diabetes, Nutrition and Weight Management, Boston University School of Medicine, Boston, MA, USA.

Marcel Ballin (M)

Department of Community Medicine and Rehabilitation, Unit of Geriatric Medicine, Umeå University, Umeå, Sweden; Department of Public Health and Clinical Medicine, Section of Sustainable Health, Umeå University, Umeå, Sweden.

Peter Nordström (P)

Department of Community Medicine and Rehabilitation, Unit of Geriatric Medicine, Umeå University, Umeå, Sweden.

Anna Nordström (A)

Department of Public Health and Clinical Medicine, Section of Sustainable Health, Umeå University, Umeå, Sweden; School of Sport Sciences, UiT The Arctic University of Norway, Tromsø, Norway.

Sigmund A Anderssen (SA)

Department of Sport Medicine, Norwegian School of Sport Sciences, Norwegian Institute of Public Health, Oslo, Norway.

Bjørge H Hansen (BH)

Department of Sport Medicine, Norwegian School of Sport Sciences, Norwegian Institute of Public Health, Oslo, Norway; Department of Sport Science and Physical Education, University of Agder, Norway.

Jennifer A Cochrane (JA)

Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.

Terence Dwyer (T)

Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK; Murdoch Children's Research Institute, Melbourne, VIC, Australia.

Jing Wang (J)

Murdoch Children's Research Institute, Melbourne, VIC, Australia.

Luigi Ferrucci (L)

Intramural Research Program, National Institute on Aging, Baltimore, MD, USA.

Fangyu Liu (F)

Department of Epidemiology, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Jennifer Schrack (J)

Department of Epidemiology, Johns Hopkins School of Medicine, Baltimore, MD, USA; Center on Aging and Health, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Jacek Urbanek (J)

Center on Aging and Health, Johns Hopkins School of Medicine, Baltimore, MD, USA; Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Pedro F Saint-Maurice (PF)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.

Naofumi Yamamoto (N)

Faculty of Collaborative Regional Innovation, Ehime University, Matsuyama, Ehime, Japan.

Yutaka Yoshitake (Y)

Institute for Pacific Rim Studies, Meio University, Nago, Okinawa, Japan.

Robert L Newton (RL)

Pennington Biomedical Research Center, Baton Rouge, LA, USA.

Shengping Yang (S)

Pennington Biomedical Research Center, Baton Rouge, LA, USA.

Eric J Shiroma (EJ)

Laboratory of Epidemiology and Population Sciences, National Institute on Aging, Baltimore, MD, USA.

Janet E Fulton (JE)

Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH